Get the latest tech news

FDA grants De Novo authorization for noninvasive device to treat varicose veins


Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins.

None

Get the Android app

Or read this on r/technology

Read more on:

Photo of FDA

FDA

Photo of De Novo

De Novo

Photo of varicose veins

varicose veins

Related news:

News photo

FDA Rejects China-Developed Cancer Drug Ivonescimab for U.S. Approval

News photo

FDA Warns GLP-1s May Increase Risk of Sudden Blindness

News photo

FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s